Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

8 projects found matching your search criteria :

  1. Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk...

    Call: OPUS 28 , Panel: ST8

    Principal investigator: dr hab. Bożena Anna Tyliszczak

    Politechnika Krakowska im. Tadeusza Kościuszki

  2. Impact of cytostatic drugs present in the environment on Gram-negative bacteria: mechanisms of adaptation and implicatio...

    Call: PRELUDIUM 23 , Panel: NZ9

    Principal investigator: Adam Grzywaczyk

    Politechnika Poznańska

  3. Design and characterisation of sealing materials of prosthetic obturator being additionally a cytostatic drug reservoir....

    Call: OPUS 26 , Panel: ST8

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

  4. Research on white-rot fungi ability to remove cytostatic drugs on an example of: bleomycin and vincristine

    Call: PRELUDIUM 19 , Panel: ST8

    Principal investigator: dr Marcelina Karolina Jureczko

    Politechnika Śląska, Wydział Inżynierii Środowiska i Energetyki

  5. The role of cancer stem cells in extracellular matrix production and drug resistance in ovarian cancer

    Call: SONATA BIS 6 , Panel: NZ5

    Principal investigator: dr hab. Radosław Januchowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  6. Developing of a new system for targeted anticancer therapy based on betulin derivetive and self-organizing polymeric nan...

    Call: HARMONIA 7 , Panel: ST5

    Principal investigator: prof. Janusz Edward Kasperczyk

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu

  7. Synthesis and structural characterization of MCM-48/nano-HA/cytostatic drug composites

    Call: PRELUDIUM 6 , Panel: ST5

    Principal investigator: dr Łukasz Maciej Pajchel

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  8. The effect of reductive activation of antitumour anthracycline antibiotics and their synthetic analogues on restoring cy...

    Call: OPUS 3 , Panel: NZ3

    Principal investigator: prof. Jolanta Tarasiuk

    Uniwersytet Szczeciński, Wydział Biologii